Azenta, Inc. (NASDAQ:AZTA) Shares Bought by Legal & General Group Plc

Legal & General Group Plc raised its holdings in Azenta, Inc. (NASDAQ:AZTA - Free Report) by 17.5% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 408,484 shares of the company's stock after purchasing an additional 60,817 shares during the period. Legal & General Group Plc owned about 0.89% of Azenta worth $20,424,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also made changes to their positions in the company. Ballentine Partners LLC boosted its holdings in Azenta by 2.0% in the 4th quarter. Ballentine Partners LLC now owns 20,340 shares of the company's stock worth $1,017,000 after buying an additional 404 shares during the last quarter. Picton Mahoney Asset Management lifted its position in shares of Azenta by 305.7% in the fourth quarter. Picton Mahoney Asset Management now owns 706 shares of the company's stock valued at $35,000 after acquiring an additional 532 shares in the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. boosted its stake in shares of Azenta by 14.9% in the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 4,446 shares of the company's stock worth $225,000 after acquiring an additional 576 shares during the last quarter. KBC Group NV increased its position in shares of Azenta by 48.5% during the fourth quarter. KBC Group NV now owns 2,137 shares of the company's stock worth $107,000 after purchasing an additional 698 shares in the last quarter. Finally, Oregon Public Employees Retirement Fund raised its stake in Azenta by 7.0% in the 4th quarter. Oregon Public Employees Retirement Fund now owns 10,700 shares of the company's stock valued at $535,000 after purchasing an additional 702 shares during the last quarter. 99.08% of the stock is currently owned by hedge funds and other institutional investors.

Azenta Stock Performance

Shares of AZTA stock traded down $0.25 on Friday, hitting $25.25. 880,637 shares of the stock traded hands, compared to its average volume of 637,738. Azenta, Inc. has a twelve month low of $24.68 and a twelve month high of $63.58. The firm's 50-day moving average price is $37.36 and its two-hundred day moving average price is $44.15. The stock has a market capitalization of $1.15 billion, a PE ratio of -8.47 and a beta of 1.66.

Azenta (NASDAQ:AZTA - Get Free Report) last issued its earnings results on Wednesday, February 5th. The company reported $0.08 EPS for the quarter, topping analysts' consensus estimates of $0.05 by $0.03. Azenta had a negative net margin of 24.91% and a positive return on equity of 1.25%. On average, equities research analysts anticipate that Azenta, Inc. will post 0.53 EPS for the current fiscal year.

Analyst Ratings Changes

Several equities research analysts have issued reports on AZTA shares. Evercore ISI lifted their target price on shares of Azenta from $50.00 to $52.00 and gave the stock an "in-line" rating in a research note on Thursday, February 6th. Needham & Company LLC boosted their price target on shares of Azenta from $55.00 to $59.00 and gave the stock a "buy" rating in a research report on Thursday, February 6th. Stephens reissued an "overweight" rating and issued a $60.00 target price on shares of Azenta in a research note on Thursday, January 2nd. Finally, TD Cowen upgraded Azenta to a "hold" rating in a research report on Thursday, February 27th.

Azenta Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.